Arkolith/Insider Trading/CVRX/Form 4

Adamson Philip B.

Chief Medical OfficerCVRx, Inc. (CVRX) · full profile →Form 4 · filed Mar 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)1K$7.90$10K62K
Feb 27, 2026Grant(A)41K—$063K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 27, 2026Grant(A)62K—$062K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002056191-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML